Labcorp Holdings Inc (LH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Labcorp Holdings Inc (Labcorp), formerly Laboratory Corporation of America Holdings, is a life sciences and healthcare company. It offers blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin AI C, health and wellness services, lead optimization, analytical services, chemistry manufacturing services, early phase development solutions, crop protection and chemical testing, clinical laboratory services, and technology solutions, among others. The company offers services to health insurance companies; pharmaceutical, biotechnology, medical device, and diagnostics companies and CROs; physicians, other healthcare providers; hospitals and health systems; governmental agencies; employers; patients and consumers; crop protection and chemical companies; academic institutions; independent clinical laboratories; and retailers; among others in the Americas, Europe, and Asia-Pacific. It operates manufacturing facilities in the US, Belgium, China, Japan, India, Germany, Singapore, the UK, and Switzerland. Labcorp is headquartered in Burlington, North Carolina, the US.
Labcorp Holdings Inc Key Recent Developments
Jun 22, 2026: Labcorp Makes ColoSense RNA-Based At-Home Colorectal Cancer Screening Available Nationwide
Jun 02, 2026: Labcorp Highlights AI Advances in Diagnostics and Alzheimer’s Research at Triad BioNight
Jun 01, 2026: Labcorp announces partnership for colorectal cancer trials
May 29, 2026: Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
May 14, 2026: Babcock & Wilcox Enterprises Proposes Public Offering of Common Stock
May 11, 2026: Babcock & Wilcox Enterprises Reports First Quarter 2026 Results
Apr 27, 2026: Bragar Eagel & Squire Urges Babcock & Wilcox Enterprises, Inc. Investors With Significant Losses to Contact Firm
Mar 04, 2026: Babcock & Wilcox Receives Full Notice to Proceed on $2.4 Billion Power Generation Project for Base Electron to Supply Power to Applied Digital AI Factory Campuses
Mar 04, 2026: Babcock & Wilcox Reports Q4 and Full-Year 2025 Results
Jan 27, 2026: Babcock & Wilcox Enterprises, Inc. Appoints Dr. Homaira Akbari to Board of Directors
Jan 09, 2026: B&W selects Siemens Energy turbines for 1GW data centre power project
Jan 08, 2026: Babcock & Wilcox Selects Siemens Energy to Supply Steam Turbine Generator Sets for Applied Digital AI Data Center Project
This product is a company SWOT Analysis. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a company SWOT Analysis. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a company SWOT Analysis. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net